• Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Social icon element need JNews Essential plugin to be activated.
Sunday, April 19, 2026
Daily The Business
  • Login
No Result
View All Result
DTB
No Result
View All Result
DTB

India markets regulator to review provisions for members’ conflict of interest

March 24, 2025
in Markets

The Securities and Exchange Board of India (SEBI) will set up a committee to review provisions related to its members’ conflict of interest, the markets regulator said on Monday in its first meeting under new chairman, Tuhin Kanta Pandey.

SEBI’s previous chief, Madhabi Puri Buch, had come under attack towards the end of her term after the now-shuttered Hindenburg Research alleged conflict of interest in investigations into the Adani group because of her previous investments, which both Buch and the Adani group denied.

Separately, the regulator also approved doubling the assets under management (AUM) threshold to 500 billion rupees ($5.84 billion) for foreign portfolio investors who need to provide granular disclosures, including the names of all stakeholders.

SEBI has, in January, proposed to raise this limit due to an increase in trading volumes and liquidity.

SEBI added that foreign investors who have 50% or more of their AUM in a single corporate group will continue to give detailed disclosure of ownership.

Previous Post

US stocks rise as White House weighs more limited tariffs

Next Post

Pakistan, Italy optimistic about energy sector collaboration

American Dollar Exchange Rate
Write us: info@dailythebusiness.com

© 2021 Daily The Business

Social icon element need JNews Essential plugin to be activated.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

© 2021 Daily The Business

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.